BlackRock Investment Management, LLC - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 63 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 590.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2016$382,000
+9.5%
82,955
+0.8%
0.00%
Q3 2016$349,000
+98.3%
82,269
+12.2%
0.00%
Q2 2016$176,000
+2.3%
73,307
+100.7%
0.00%
Q1 2016$172,000
+22.9%
36,525
+2.2%
0.00%
Q4 2015$140,000
+1.4%
35,7500.0%0.00%
Q3 2015$138,000
-17.4%
35,750
-1.8%
0.00%
Q2 2015$167,00036,3980.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$17,019,0002.88%
Northeast Financial Consultants Inc 732,265$3,368,0001.50%
Family Management Corp 12,008$55,0000.04%
Acrospire Investment Management LLC 6,101$28,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$681,0000.01%
THRIVENT FINANCIAL FOR LUTHERANS 413,278$1,901,0000.01%
OXFORD ASSET MANAGEMENT LLP 48,790$224,0000.01%
Parallel Advisors, LLC 3,538$16,0000.00%
Squarepoint Ops LLC 15,690$72,0000.00%
WILLIAMS JONES & ASSOCIATES LLC 15,100$69,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders